Charles D Pendleton

Title: The Innovative Contributions of Charles D Pendleton

Introduction

Charles D Pendleton is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of immunology, particularly in the development of peptides that stimulate cytotoxic T cells immune to HIV reverse transcriptase. His work is crucial in the ongoing fight against human immunodeficiency virus (HIV).

Latest Patents

Pendleton holds a patent for a peptide with the amino acid sequence Glu-Ile-Cys-Thr-Glu-Met-Glu-Lys-Glu-Gly-Lys-Ile-Ser-Lys-Ile-Gly-Pro. This peptide is derived from a conserved epitope of HIV-1 reverse transcriptase. The invention may be utilized in treating patients with HIV or in preventing infection in individuals exposed to the virus but who have not yet become sero-positive. The preparation containing this peptide can be administered subcutaneously, intramuscularly, or intravenously. He has 1 patent to his name.

Career Highlights

Pendleton works for the United States of America as Represented by the Department of Health. His role involves significant research and development in the field of immunology, focusing on innovative solutions to combat HIV.

Collaborations

Some of his notable coworkers include Ronald N Germain and Jay A Berzofsky. Their collaborative efforts contribute to advancing research in immunology and the development of effective treatments for HIV.

Conclusion

Charles D Pendleton's work exemplifies the impact of innovative research in the medical field. His contributions to peptide development are vital in the fight against HIV, showcasing the importance of scientific advancements in improving public health.